Fig. 1: Integrating speech and language markers into clinical practice for Parkinson’s disease screening, diagnosis, differential diagnosis, subtyping and monitoring.
From: Speech and language biomarkers for Parkinson’s disease prediction, early diagnosis and progression
This schematic demonstrates how integrating speech and language markers into clinical practice across the Parkinson’s disease (PD) continuum can enhance early detection, inform clinical decision-making and optimize disease management throughout its progression.
